Jeito Capital to sell EyeBiotech to Merck & Co for $3bn
EyeBiotech is a clinical-stage ophthalmology biotechnology company.
EyeBiotech is a clinical-stage ophthalmology biotechnology company.
Copyright PEI Media
Not for publication, email or dissemination
